Swiss Stocks Slide On Novartis Experimental Drug Setback

Switzerland's equity market remained in negative territory for most of Tuesday's session, driven largely by heavy selling in Novartis shares. The report signals company-specific pressure in the pharmaceutical heavyweight rather than a broader quantified market catalyst.